Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1
- PMID: 32598938
- PMCID: PMC8170701
- DOI: 10.1016/j.jmb.2020.06.021
Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1
Abstract
Huntington's disease is a progressive neurodegenerative disease caused by expansion of the polyglutamine domain in the first exon of huntingtin (HttEx1). The extent of expansion correlates with disease progression and formation of amyloid-like protein deposits within the brain. The latter display polymorphism at the microscopic level, both in cerebral tissue and in vitro. Such polymorphism can dramatically influence cytotoxicity, leading to much interest in the conditions and mechanisms that dictate the formation of polymorphs. We examine conditions that govern HttEx1 polymorphism in vitro, including concentration and the role of the non-polyglutamine flanking domains. Using electron microscopy, we observe polymorphs that differ in width and tendency for higher-order bundling. Strikingly, aggregation yields different polymorphs at low and high concentrations. Narrow filaments dominate at low concentrations that may be more relevant in vivo. We dissect the role of N- and C-terminal flanking domains using protein with the former (httNT or N17) largely removed. The truncated protein is generated by trypsin cleavage of soluble HttEx1 fusion protein, which we analyze in some detail. Dye binding and solid-state NMR studies reveal changes in fibril surface characteristics and flanking domain mobility. Higher-order interactions appear facilitated by the C-terminal tail, while the polyglutamine forms an amyloid core resembling those of other polyglutamine deposits. Fibril-surface-mediated branching, previously attributed to secondary nucleation, is reduced in absence of httNT. A new model for the architecture of the HttEx1 filaments is presented and discussed in context of the assembly mechanism and biological activity.
Keywords: Huntington's disease; MAS ssNMR; TEM; amyloid; supramolecular assembly.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
Similar articles
-
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731. Biochem Soc Trans. 2024. PMID: 38563485 Free PMC article. Review.
-
Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils.Biochemistry. 2017 Jul 18;56(28):3579-3586. doi: 10.1021/acs.biochem.7b00138. Epub 2017 Jul 7. Biochemistry. 2017. PMID: 28621522 Free PMC article.
-
Self-assembly of Mutant Huntingtin Exon-1 Fragments into Large Complex Fibrillar Structures Involves Nucleated Branching.J Mol Biol. 2018 Jun 8;430(12):1725-1744. doi: 10.1016/j.jmb.2018.03.017. Epub 2018 Mar 28. J Mol Biol. 2018. PMID: 29601786
-
The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1.J Mol Biol. 2021 Oct 15;433(21):167222. doi: 10.1016/j.jmb.2021.167222. Epub 2021 Sep 4. J Mol Biol. 2021. PMID: 34492254
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
Cited by
-
Quantitative NMR analysis of the kinetics of prenucleation oligomerization and aggregation of pathogenic huntingtin exon-1 protein.Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2207690119. doi: 10.1073/pnas.2207690119. Epub 2022 Jul 12. Proc Natl Acad Sci U S A. 2022. PMID: 35858329 Free PMC article.
-
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731. Biochem Soc Trans. 2024. PMID: 38563485 Free PMC article. Review.
-
Nucleation of Huntingtin Aggregation Proceeds via Conformational Conversion of Pre-Formed, Sparsely-Populated Tetramers.Adv Sci (Weinh). 2024 Jun;11(24):e2309217. doi: 10.1002/advs.202309217. Epub 2024 Mar 12. Adv Sci (Weinh). 2024. PMID: 38476051 Free PMC article.
-
Site-Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases.Chembiochem. 2021 Jan 5;22(1):217-231. doi: 10.1002/cbic.202000508. Epub 2020 Oct 13. Chembiochem. 2021. PMID: 32805086 Free PMC article.
-
Cryo-electron tomography provides topological insights into mutant huntingtin exon 1 and polyQ aggregates.Commun Biol. 2021 Jul 8;4(1):849. doi: 10.1038/s42003-021-02360-2. Commun Biol. 2021. PMID: 34239038 Free PMC article.
References
-
- Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington Disease. Nat Rev Dis Primers. 2015;1:15005. - PubMed
-
- Mangiarini L, Sathasivam K, Seller M, Cozens BA, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493–506. - PubMed
-
- DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277:1990–3. - PubMed
-
- Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017;86:27–68. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
